Blame distrust of the response to COVID-19 for declining childhood vaccinations
The collapse reflects a widespread and mounting distrust of public health authorities, and the reason for that distrust is no mystery.
5 years after first Covid case, why can’t Hong Kong make home-grown vaccines?
In this series to mark five years since Hong Kong recorded its first Covid-19 case on January 22, 2020, the Post looks at how ...
Takeaways from RFK Jr.’s first confirmation hearing as Trump’s nominee for health secretary
Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion and public health priorities in the first of two ...
New vaccine from MIT and Caltech could prevent future coronavirus outbreaks
Traditional vaccines typically focus on the most accessible parts of viruses, which are often the rapidly mutating ...
STAT1d
In RFK Jr.’s emails to his niece, a trail of vaccine criticism
STAT annotates emails physician Kerry Kennedy Meltzer received from her uncle, Robert F. Kennedy Jr., commenting on the ...
Arcturus: Downgrading As mRNA Promise Meets Market Reality
Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...
Four Years After Covid-19 Success, mRNA Vaccines Aren’t Ready for Bird Flu
While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.
A new vaccine approach could help combat future coronavirus pandemics
A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.
pharmaphorum3d
Sanofi/GSK restart COVID-19 vaccine trials after tweaking formulation
Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag late last year. In December interim phase 1/2 trial results showed ...
WhatsApp groups spread more false Covid claims than social media – Badenoch
The things that really concern me are the pieces of information that are less visible,’ the Tory leader told the UK Covid-19 ...
pharmaphorum2d
Novavax is latest biotech to begin coronavirus vaccine trial
Maryland-based Novavax said it had enrolled the first participants in a phase 1/2 clinical trial of its coronavirus vaccine candidate. The vaccine, NVX-CoV2373, is a stable, prefusion protein ...